The efficacy of gemtuzumab ozogamicin in patients with acute leukemia: a single center experience

被引：0
|
作者：
Hosono, Naoko [1 ]
Yamauchi, Takahiro [1 ]
Matsuda, Yasufumi [1 ]
Kishi, Shinji [1 ]
Urasaki, Yoshimasa [1 ]
Yoshida, Akira [1 ]
Ueda, Takanori [1 ]
机构：
[1] Univ Fukui, Fac Med Sci, Dept Hematol & Oncol, Fukui, Japan
来源：
ANNALS OF ONCOLOGY | 2015年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O1-11-2
引用
收藏
页码：84 / 85
页数：2
相关论文
共 50 条
  • [41] Population Pharmacokinetic Modeling of Gemtuzumab Ozogamicin in Adult Patients with Acute Myeloid Leukemia
    Jennifer Hibma
    Beverly Knight
    Clinical Pharmacokinetics, 2019, 58 : 335 - 347
  • [42] Gemtuzumab ozogamicin for the treatment of acute promyelocytic leukemia: mechanisms of action and resistance, safety and efficacy
    Breccia, Massimo
    Lo-Coco, Francesco
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2011, 11 (02) : 225 - 234
  • [43] Population Pharmacokinetic Modeling of Gemtuzumab Ozogamicin in Adult Patients with Acute Myeloid Leukemia
    Hibma, Jennifer
    Knight, Beverly
    CLINICAL PHARMACOKINETICS, 2019, 58 (03) : 335 - 347
  • [44] Azacitidine combined with gemtuzumab ozogamicin in patients with relapsed/refractory acute myeloid leukemia
    Bayraktar, Ulas Darda
    Domingo, Gelenis Calzadilla
    Schmit, Jessica
    Pereira, Denise
    LEUKEMIA & LYMPHOMA, 2011, 52 (05) : 913 - 915
  • [45] A final analysis of the efficacy and safety of gemtuzumab ozogamicin in 277 patients with acute myeloid leukemia in first relapse.
    Larson, RA
    Sievers, EL
    Stadtmauer, EA
    Löwenberg, B
    Estey, E
    Dombret, H
    Theobald, M
    Voliotis, D
    Leopold, LH
    Riche, M
    Berger, MS
    Sherman, ML
    Appelbaum, FR
    BLOOD, 2002, 100 (11) : 338A - 338A
  • [46] Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse
    Sievers, EL
    Larson, RA
    Stadtmauer, EA
    Estey, E
    Löwenberg, B
    Dombret, H
    Karanes, C
    Theobald, M
    Bennett, JM
    Sherman, ML
    Berger, MS
    Eten, CB
    Loken, MR
    van Dongen, JJM
    Bernstein, ID
    Appelbaum, FR
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (13) : 3244 - 3254
  • [47] The efficacy and safety of gemtuzumab ozogamicin (CMA-676) in patients with acute myeloid leukemia in first relapse.
    Voliotis, D
    Mineur, P
    Dombret, H
    Theobald, M
    Boogaerts, M
    Löwenberg, B
    Sievers, EL
    Larson, RA
    Estey, E
    Diehl, V
    Stadtmauer, EA
    ANNALS OF ONCOLOGY, 2000, 11 : 95 - 95
  • [48] Gemtuzumab ozogamicin in the treatment of critically ill patients with refractory acute myeloid leukemia
    Zaytsev, D.
    Girshova, L.
    Ivanov, V.
    Budaeva, I.
    Motorin, D.
    Badaev, R.
    Bogdanov, K.
    Mirolubova, J.
    Nikulina, T.
    Chitanava, T.
    Alexeeva, J.
    Zaritskey, A.
    LEUKEMIA RESEARCH, 2019, 85 : S65 - S66
  • [49] The Use of Gemtuzumab Ozogamicin As Salvage Therapy in Patients With Acute Myeloid Leukemia: A Monocentric Real-World Experience
    Acar, Ibrahim Halil
    Guvenc, Birol
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S271 - S272
  • [50] The safety and myelotoxicity of gemtuzumab ozogamicin (Mylotarg®) in adult acute myeloid leukemia in complete remission:: A single institution experience.
    Zimmerman, DM
    Petruska, PJ
    Pincus, SM
    BLOOD, 2001, 98 (11) : 225B - 225B
12345